Literature DB >> 28497003

Achondroplasia and Biliary Atresia: A Rare Association and Review of Literature.

Ranjit I Kylat1.   

Abstract

Achondroplasia (ACH) occurs in most cases as de novo mutations of the gene-encoding fibroblast growth factor receptor 3 (FGFR3). Biliary atresia (BA) is a progressive neonatal inflammatory and fibro-obliterative cholangiopathy affecting the extra- and intrahepatic biliary tree to varying degrees, and it results in obstruction to bile flow and cholestatic jaundice in neonates. BA is thought to be a multifactorial disease, genome association studies have shown abnormalities in susceptibility genes, and levels of fibroblast growth factor 21 (FGF21) and fibroblast growth factor 23 (FGF23) have been noted to be increased. These two conditions occurring in the same patient has never been reported before.

Entities:  

Keywords:  achondroplasia; biliary atresia; fibroblast growth factor 21; fibroblast growth factor 23; fibroblast growth factor receptor 3; fibroblast growth factors; glypican 1; skeletal dysplasia

Year:  2017        PMID: 28497003      PMCID: PMC5423800          DOI: 10.1055/s-0036-1597930

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  32 in total

Review 1.  Genetic contributors and modifiers of biliary atresia.

Authors:  Anya Mezina; Saul J Karpen
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 2.  Genome-wide association studies in biliary atresia.

Authors:  Mylarappa Ningappa; Jun Min; Brandon W Higgs; Chethan Ashokkumar; Sarangarajan Ranganathan; Rakesh Sindhi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-05-11

Review 3.  Co-occurrence of achondroplasia and Down syndrome: Genotype/phenotype association.

Authors:  Lilia Maria de Azevedo Moreira; Marcos A Matos; Patricia P Schiper; Acácia F L Carvalho; Ivalda C Gomes; José C Rolemberg; Renata L L Ferreira de Lima; Maria B P Toralles
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-04

4.  Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene.

Authors:  Shuang Cui; Melissa Leyva-Vega; Ellen A Tsai; Steven F EauClaire; Joseph T Glessner; Hakon Hakonarson; Marcella Devoto; Barbara A Haber; Nancy B Spinner; Randolph P Matthews
Journal:  Gastroenterology       Date:  2013-01-18       Impact factor: 22.682

Review 5.  Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations.

Authors:  R Carmi; C A Magee; C A Neill; F M Karrer
Journal:  Am J Med Genet       Date:  1993-03-15

Review 6.  International incidence and outcomes of biliary atresia.

Authors:  Carolina Jimenez-Rivera; Kheira S Jolin-Dahel; Kyle J Fortinsky; Peter Gozdyra; Eric I Benchimol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

7.  Common genetic variants of GPC1 gene reduce risk of biliary atresia in a Chinese population.

Authors:  Juntao Ke; Shuaidan Zeng; Jianxiong Mao; Jianyao Wang; Jiao Lou; Jiaoyuan Li; Xueqin Chen; Cheng Liu; Liu-Ming Huang; Bin Wang; Lei Liu
Journal:  J Pediatr Surg       Date:  2016-05-31       Impact factor: 2.545

8.  Expression of fibroblast growth factor 21 in patients with biliary atresia.

Authors:  Dawei Li; Tianfei Lu; Conghuan Shen; Yuan Liu; Jiang Zhang; Yuhua Shan; Yi Luo; Zhifeng Xi; Bijun Qiu; Qimin Chen; Jianjun Zhang; Qiang Xia
Journal:  Cytokine       Date:  2016-03-21       Impact factor: 3.861

9.  Hepatic fibrosis in Kabuki syndrome.

Authors:  Valerio Nobili; Matilde Marcellini; Rita Devito; Rossella Capolino; Laura Viola; M Cristina Digilio
Journal:  Am J Med Genet A       Date:  2004-01-15       Impact factor: 2.802

Review 10.  Achondroplasia.

Authors:  William A Horton; Judith G Hall; Jacqueline T Hecht
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.